What's breaking now, across thousands of outlets.
CEO Dave Ricks built Eli Lilly into the first $1 trillion pharma company with its blockbuster weight-loss and diabetes drugs. But with more than 60% of revenue coming from them, the drug giant faces the risks of its own success.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
In recent trading, shares of BSP (Symbol: BSP) have crossed above the average analyst 12-month target price of $46.40, changing hands for $53.69/share.
In recent trading, shares of Consolidated Edison Inc (Symbol: ED) have crossed above the average analyst 12-month target price of $108.44, changing hands for $109.60/share.
In recent trading, shares of FIGS Inc (Symbol: FIGS) have crossed above the average analyst 12-month target price of $18.22, changing hands for $18.63/share.
CHICAGO — Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the…
My morning reads: • The Nobel Prize Message for Kevin Warsh: “Clear and credible communication about how [central banks] reason and what they plan to do has become vital to their operations,” the…
(RTTNews) - The DAX benchmark that tracks the performance of the 40 largest companies listed on the Frankfurt Stock Exchange declined on Thursday amidst worries over artificial intelligence and fears…
